Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dalteparin vs Placebo in Advanced Cancer
NCT00003674Phase 3Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Dec 1998
- Primary completion
- Apr 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of dalteparin in breast cancer, lung cancer, colorectal cancer (CRC), prostate cancer (PCa), sponsored by Cancer and Leukemia Group B. Started Dec 1998; status: completed.
02
Drugs
dalteparin
03
Conditions
breast cancerlung cancercolorectal cancer (CRC)prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00003674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003674.